Navigation Links
HCV Patients Survival After Liver Transplantation is Not Improving

For liver transplant recipients without hepatitis C (HCV), survival has improved over time. However, for recipients with HCV, survival has not improved , according to a study in the issue of Liver Transplantation.

HCV-induced liver disease is the most common reason for liver transplantation in the U.S., however, previous studies have shown that these patients do not respond as well to liver transplantation. The difference has become even more striking in recent years, leading some to suggest that survival rates have been decreasing for patients with HCV who have received transplants.

Researchers led by Paul Thuluvath of The Johns Hopkins School of Medicine in Baltimore, MD, sought to study a large sample of the liver transplant population to determine if there has indeed been a decline in survival among HCV patients after adjusting for possible confounding factors.

They gathered data from the United Network for Organ Sharing on all adult liver transplantation performed in the U.S. between January 1991 and October 2001. They included 5,708 HCV patients and 16,116 non-HCV patients and performed multivariate analysis to determine the impact of confounding factors on survival.

The proportion of liver transplant patients with HCV increased dramatically over the study time period, from 16.4 percent in 1991 to 54.7 percent in 2001. However, patients with HCV had a lower 3-year survival (78.5 percent) compared to non-HCV patients (81.7 percent.) For the former group, there was no improvement in survival during the study period, in contrast to the latter group.

"In summary, the survival of patients transplanted with HCV is significantly lower than those without HCV," the authors report. "There has been a statistically significant improvement in patient and graft survival for non-HCV recipients between 1991 and 2001, but for HCV recipients, the survival rate has remained unchanged without any obvious exp
'"/>




Page: 1 2

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
(Date:10/10/2008)... Honoring excellence in the impl...e Healthcare Information and Management Systems So... Davies Awards in the Organizational, Ambulatory a... Chicago, IL (PRWEB) October ...ion of electronic health records (EHRs), the Heal...
(Date:10/10/2008)...n, MABoston Medical Center (BMC) has received a $5...nstitute on Aging (NIA) to fund the Boston Claude ...,s Pepper Center is one of only 11 Pepper Centers ...ericans Independence Center Program was establishe...tor from Florida. During his five decades of publi...
(Date:10/10/2008)...LADELPHIA, Oct. 10 /PRNewswire/ -- The Mobile Mass...eading provider of on-site seated massage,services...ts, and special,affairs, announced today that it i...nnsylvania and the greater Philadelphia metropolit...asing interest in our on-site,seated, massage pro...
(Date:10/9/2008)...ding Melanoma Specialists Will Give Accredited Cou...agement of Melanoma, To be held November 1, 2008 ... CONCORD, Mass., Oct. 9 /PRNewswire-USNewswire/ --...ston University School of Medicine are,co-sponsori... Education,(ACCME) course to update non-dermatolog...
Breaking Medicine News(10 mins):Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Boston Medical Center receives $5.8m grant 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Paul Sullivan's Legacy: An Early Warning Program for Detecting Melanoma Before It's Too Late 2
...proved a novel molecular drug that is capable of p...nts// including those whose immune systems are wea... permitted for use, as a prevention of infections ...ike fungi called Aspergillus and Candida. This fun...
...sal airway function in patients with severe nasal ...mber/October issue of Archives of Facial Plastic S...tion of the nasal passages is one of the most comm...ists and facial plastic surgeons, according to bac...
...igarh's rural areas and colonies has come down, sa...ealth department official said Tuesday the survey ...alnutrition had come down by 22 percent in the las...l scheme was introduced in some government schools...
...e risk of liver damage or disruption in mental hea...nd in plastic and other soft toys //sold in Delhi,...levels of lead and cadmium have been found in PVC ...ng sold in the markets," said Toxics Link, an envi...
Other Medicine News:Health News:Nasal Plastic Surgery Improves Airway Function 2Health News:Dangers Lurking in Soft, Cuddly Toys 2
(Date:10/10/2008)... Calif., Oct. 10 /-,XTENT, ...s to present,long-term follow-up data from the CUS... Cardiovascular Research Foundation,s (CRF) twenti...cs (TCT) meeting in Washington, DC.,The CUSTOM cli...nvestigate,the safety and efficacy of the Custom N...
(Date:10/10/2008)...xis Treatment with Kogenate FS Reduces the,Risk of... No Pre-Existing,Joint Damage, BERKELEY, Calif., ...nced today that the U.S. Food and Drug Administrat...genate(R) FS Antihemophilic Factor,(Recombinant) t...e risk of,joint damage in patients aged 0-16 years...
(Date:10/10/2008)...Newswire-FirstCall/ -- Boston Scientific,Corporati...he Company,s major,events and press announcements ...twentieth annual Transcatheter Cardiovascular Ther...om October 12 to 17 in Washington, D.C., Boston S...y and,efficacy data on its TAXUS(R) Express2(TM) a...
(Date:10/9/2008)... Spread Awareness and Bring Hope to Millions,of Ch...Newswire/ -- 133 million children,across the globe...atural,disaster, civil war, and disease. SOS Child...phan Week by calling attention to the needs of orp...ase, go to:, http://www.prnewswire.com/mnr/sosch...
Breaking Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2CCMR gets 242 9M for training grad students in nanoscale science 744 1CCMR gets 242 9M for training grad students in nanoscale science 744 2Smart insulin nanostructures pass feasibility test UT study reports 740 1Smart insulin nanostructures pass feasibility test UT study reports 740 2Friends of Mel Announce Recall of Jewelry Due to Lead 1755 1Friends of Mel Announce Recall of Jewelry Due to Lead 1755 2Friends of Mel Announce Recall of Jewelry Due to Lead 1755 3ABC TV San Francisco Features Canine Cancer Research Story 3A Saving Our Dogs Helping Humans Beat Cancer Work at Morris Animal Foundation UC Davis 1751 1ABC TV San Francisco Features Canine Cancer Research Story 3A Saving Our Dogs Helping Humans Beat Cancer Work at Morris Animal Foundation UC Davis 1751 2
...NOVIVE Pharmaceuticals,Inc. (OTCBB: IVPH) today a... INNO-406, an orally bioavailable dual Bcr-Abl and...treatment-intolerant chronic myelogenous leukemia,... Clinical Oncology Annual,Meeting. The meeting tak...cago, Illinois., Information related to the presen...
.../ -- Vical,Incorporated today announced that a mea...fectin(TM) adjuvant elicited protective,levels of ...d),nonhuman primates confirmed by complete protect...accination, and sterilizing,immunity as evidenced ...virus after challenge. In a separate study, the sa...
Other Medicine Technology:Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 2Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 3Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 4
Ascent Anterior Referencing Femoral Instrument Case
The Lineage acetabular system with metal liners uses sophisticated manufacturing methods and materials to minimize wear debris generation.
The Pivot Bipolar was designed with a simple one-step assembly interface between the femoral head and the compression molded liner which requires no instruments and reduces OR time.
Derived from an extensive study into increasing the range of motion in hip replacement, the cemented SHP acetabular cup is a unique design and is manufactured from ArCom polyethylene.
Medicine Products: